Cleared Traditional

K940221 - ACCESS CORTISOL REAGENTS

K940221 is the FDA 510(k) clearance for ACCESS CORTISOL REAGENTS by Bio-Rad Laboratories, Inc.. It is a Class 2 Toxicology device (product code CGR) cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K940221 · Bio-Rad Laboratories, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1994
Decision
98d
Days
Class 2
Risk

K940221 is an FDA 510(k) clearance for the ACCESS CORTISOL REAGENTS. Classified as Radioimmunoassay, Cortisol (product code CGR), Class II - Special Controls.

Submitted by Bio-Rad Laboratories, Inc. (Chaska, US). The FDA issued a Cleared decision on April 26, 1994 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.1205 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Bio-Rad Laboratories, Inc. devices

Submission Details

510(k) Number K940221 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 18, 1994
Decision Date April 26, 1994
Days to Decision 98 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 87d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGR Radioimmunoassay, Cortisol
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1205
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - CGR Radioimmunoassay, Cortisol

All 42
Devices cleared under the same product code (CGR) and FDA review panel - the closest regulatory comparables to K940221.
NICHOLS ADVANTAGE CHEMILUMINESCENCE CORTISOL KIT
K962208 · Nichols Institute Diagnostics · Apr 1997
ACCESS CORTISOL ASSAY (MODIFICATION)
K954733 · Bio-Rad Laboratories, Inc. · Dec 1995
CIBA CORNING ACS CORTISOL IMMUNOASSAY
K945367 · Ciba Corning Diagnostics Corp. · May 1995
SYNELISA CORTISOL
K931177 · Elias U.S.A., Inc. · Sep 1993
IMMULITE CORTISOL
K931409 · Diagnostic Products Corp. · May 1993
ENZYMUN TEST(R) CORTISOL
K900485 · Boehringer Mannheim Corp. · May 1990